Literature DB >> 1336117

Rodent and human beta 3-adrenergic receptor genes contain an intron within the protein-coding block.

J G Granneman1, K N Lahners, D D Rao.   

Abstract

DNA blot analysis of the cloned rat beta 3-adrenergic receptor gene revealed unexpected restriction enzyme cleavage sites that suggested the presence of one or more introns near the end of the coding block. This region of the rat gene was mapped and sequenced and was found to contain two introns. The first intron occurs 12 amino acids from the end of the coding block, as deduced by comparison with the beta 3 receptor cDNA. Sequence analysis of the first intron indicates that it might contain enhancer elements that could be important in the adipose tissue-specific expression of this gene. The mouse and human beta 3 receptor genes have been assumed to be intronless; however, these genes contain potential splice sites that are homologous to those present in the rat gene. The relevant regions of the mouse and human beta 3 receptor cDNAs were cloned and, by comparing them to the respective genomic sequences, it was concluded that these genes also contain one or more introns. Sequence analysis of the mouse and human beta 3 receptor cDNAs indicates that they code for proteins that are, respectively, 12 and 6 amino acids larger than previously deduced from genomic clones.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1336117

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  16 in total

1.  Alternative splicing generates two isoforms of the beta3-adrenoceptor which are differentially expressed in mouse tissues.

Authors:  B A Evans; M Papaioannou; S Hamilton; R J Summers
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 2.  Agonist-induced desensitisation of β3 -adrenoceptors: Where, when, and how?

Authors:  Katerina Okeke; Stephane Angers; Michel Bouvier; Martin C Michel
Journal:  Br J Pharmacol       Date:  2019-04-07       Impact factor: 8.739

3.  β(3) Receptors: Role in Cardiometabolic Disorders.

Authors:  Shraddha V Bhadada; Bhoomika M Patel; Anita A Mehta; Ramesh K Goyal
Journal:  Ther Adv Endocrinol Metab       Date:  2011-04       Impact factor: 3.565

Review 4.  Tools to study beta3-adrenoceptors.

Authors:  Wim Vrydag; Martin C Michel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-01-09       Impact factor: 3.000

Review 5.  Adrenergic regulation of cellular plasticity in brown, beige/brite and white adipose tissues.

Authors:  Vanesa D Ramseyer; James G Granneman
Journal:  Adipocyte       Date:  2016-02-18       Impact factor: 4.534

Review 6.  Renaissance of brown adipose tissue research: integrating the old and new.

Authors:  J G Granneman
Journal:  Int J Obes Suppl       Date:  2015-08-04

7.  Functional diversity of AT2 receptor orthologues in closely related species.

Authors:  Ying-Hong Feng; Lingyin Zhou; Yan Sun; Janice G Douglas
Journal:  Kidney Int       Date:  2005-05       Impact factor: 10.612

8.  Expression of beta 3-adrenoceptor mRNA in rat tissues.

Authors:  B A Evans; M Papaioannou; V R Bonazzi; R J Summers
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

9.  In situ assessment of the role of the beta 1-, beta 2- and beta 3-adrenoceptors in the control of lipolysis and nutritive blood flow in human subcutaneous adipose tissue.

Authors:  P Barbe; L Millet; J Galitzky; M Lafontan; M Berlan
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

10.  A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys.

Authors:  M H Fisher; A M Amend; T J Bach; J M Barker; E J Brady; M R Candelore; D Carroll; M A Cascieri; S H Chiu; L Deng; M J Forrest; B Hegarty-Friscino; X M Guan; G J Hom; J E Hutchins; L J Kelly; R J Mathvink; J M Metzger; R R Miller; H O Ok; E R Parmee; R Saperstein; C D Strader; R A Stearns; D E MacIntyre
Journal:  J Clin Invest       Date:  1998-06-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.